186 related articles for article (PubMed ID: 18649392)
21. [Assessing quality of life in Parkinson's disease using the PDQ-39. A pilot study].
Martínez-Martín P; Frades Payo B; Fontán Tirado C; Martínez Sarriés FJ; Guerrero MT; del Ser Quijano T
Neurologia; 1997 Feb; 12(2):56-60. PubMed ID: 9147452
[TBL] [Abstract][Full Text] [Related]
22. Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages.
Virués-Ortega J; Rodríguez-Blázquez C; Micheli F; Carod-Artal FJ; Serrano-Dueñas M; Martínez-Martín P
Mov Disord; 2010 Jul; 25(10):1391-8. PubMed ID: 20310036
[TBL] [Abstract][Full Text] [Related]
23. The clinically important difference on the unified Parkinson's disease rating scale.
Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal metric properties of disability rating scales for Parkinson's disease.
Martinez-Martin P; Prieto L; Forjaz MJ
Value Health; 2006; 9(6):386-93. PubMed ID: 17076869
[TBL] [Abstract][Full Text] [Related]
25. [Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language].
Martínez-Martín P; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
Rev Neurol; 2008 Oct 1-15; 47(7):337-43. PubMed ID: 18841543
[TBL] [Abstract][Full Text] [Related]
26. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
Martignoni E; Franchignoni F; Pasetti C; Ferriero G; Picco D
Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
[TBL] [Abstract][Full Text] [Related]
27. Impact of the motor complications of Parkinson's disease on the quality of life.
Chapuis S; Ouchchane L; Metz O; Gerbaud L; Durif F
Mov Disord; 2005 Feb; 20(2):224-30. PubMed ID: 15384126
[TBL] [Abstract][Full Text] [Related]
28. The lower-limb tasks questionnaire: an assessment of validity, reliability, responsiveness, and minimal important differences.
McNair PJ; Prapavessis H; Collier J; Bassett S; Bryant A; Larmer P
Arch Phys Med Rehabil; 2007 Aug; 88(8):993-1001. PubMed ID: 17678661
[TBL] [Abstract][Full Text] [Related]
29. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precision.
Martinez-Martin P; Forjaz MJ
Mov Disord; 2006 Aug; 21(8):1182-8. PubMed ID: 16673397
[TBL] [Abstract][Full Text] [Related]
30. Most of the Quality of Life in Essential Tremor Questionnaire (QUEST) psychometric properties resulted in satisfactory values.
Martínez-Martín P; Jiménez-Jiménez FJ; Carroza García E; Alonso-Navarro H; Rubio L; Calleja P; Díaz-Sánchez M; Benito-León J
J Clin Epidemiol; 2010 Jul; 63(7):767-73. PubMed ID: 19959331
[TBL] [Abstract][Full Text] [Related]
31. Psychometric properties of the Parkinson's Disease Sleep Scale--Brazilian version.
Margis R; Donis K; Schönwald SV; Fagondes SC; Monte T; Martín-Martínez P; Chaudhuri KR; Kapczinski F; Rieder CR
Parkinsonism Relat Disord; 2009 Aug; 15(7):495-9. PubMed ID: 19211294
[TBL] [Abstract][Full Text] [Related]
32. Burden, perceived health status, and mood among caregivers of Parkinson's disease patients.
Martinez-Martin P; Arroyo S; Rojo-Abuin JM; Rodriguez-Blazquez C; Frades B; de Pedro Cuesta J;
Mov Disord; 2008 Sep; 23(12):1673-80. PubMed ID: 18709684
[TBL] [Abstract][Full Text] [Related]
33. Psychometric testing confirms that the Brazilian-Portuguese adaptations, the original versions of the Fear-Avoidance Beliefs Questionnaire, and the Tampa Scale of Kinesiophobia have similar measurement properties.
de Souza FS; Marinho Cda S; Siqueira FB; Maher CG; Costa LO
Spine (Phila Pa 1976); 2008 Apr; 33(9):1028-33. PubMed ID: 18427325
[TBL] [Abstract][Full Text] [Related]
34. Assessment of psychiatric complications in Parkinson's disease: The SCOPA-PC.
Visser M; Verbaan D; van Rooden SM; Stiggelbout AM; Marinus J; van Hilten JJ
Mov Disord; 2007 Nov; 22(15):2221-8. PubMed ID: 17712843
[TBL] [Abstract][Full Text] [Related]
35. Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT).
Rodriguez-Blazquez C; Forjaz MJ; Frades-Payo B; de Pedro-Cuesta J; Martinez-Martin P;
Eur J Neurol; 2010 Feb; 17(2):194-201. PubMed ID: 19780808
[TBL] [Abstract][Full Text] [Related]
36. Testing the validity of the PDQ-39 in patients with MSA.
Schrag A; Jenkinson C; Selai C; Mathias C; Quinn N
Parkinsonism Relat Disord; 2007 Apr; 13(3):152-6. PubMed ID: 17070089
[TBL] [Abstract][Full Text] [Related]
37. Independent validation of the non motor symptoms scale for Parkinson's disease in Brazilian patients.
Carod-Artal FJ; Martinez-Martin P
Parkinsonism Relat Disord; 2013 Jan; 19(1):115-9. PubMed ID: 22981311
[TBL] [Abstract][Full Text] [Related]
38. Two questionnaires for Parkinson's disease: are the PDQ-39 and PDQL equivalent?
Martinez-Martin P; Serrano-Dueñas M; Forjaz MJ; Serrano MS
Qual Life Res; 2007 Sep; 16(7):1221-30. PubMed ID: 17534735
[TBL] [Abstract][Full Text] [Related]
39. [Validation of the Japanese version of the Parkinson's Disease Questionnaire].
Kohmoto J; Ohbu S; Nagaoka M; Suzukamo Y; Kihira T; Mizuno Y; Ito YM; Hith M; Yamaguchi T; Ohashi Y; Fukuhara S; Kondo T
Rinsho Shinkeigaku; 2003 Mar; 43(3):71-6. PubMed ID: 12820553
[TBL] [Abstract][Full Text] [Related]
40. Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile.
Hagell P; Whalley D; McKenna SP; Lindvall O
Mov Disord; 2003 Jul; 18(7):773-83. PubMed ID: 12815656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
